accessibilityalertarrow-downarrow-leftarrow-rightarrow-upchevron-downchevron-leftchevron-rightchevron-upclosedigital-transformationdiversitydownloaddrivedropboxeventsexitexpandfacebookguideinstagramjob-pontingslanguage-selectorlanguagelinkedinlocationmailmenuminuspencilphonephotoplayplussearchsharesoundshottransactionstwitteruploadwebinarwp-searchwt-arrowyoutube
Press Release Press Release

Wolf Theiss advises Investindustrial on the sale of Lifebrain to Cerba HealthCare

Wolf Theiss advised on all Austrian law aspects of the sales process. The signing took place on 18 July 2021, the transaction is subject to merger control and regulatory clearances.

Wolf Theiss regularly and comprehensively advises Lifebrain Group also on various orther legal matters related to the group’s activities in Austria, including in connection with permits, procurement procedures, employment law matters, IP/IT and data protection. Led by Partner Clara Gordon (Corporate/M&A), the Wolf Theiss team advising in connection with the sales process consisted of the following experts: Consultant Carolin Ziegler, Associates Peter Pichlmayr, Paul Berger and Manuela Regner (Corporate/M&A); Partner Kurt Retter, Senior Associate Harald Strahberger and Associate Dominik Engel (Regulatory); Partners Roland Marko and Georg Kresbach as well as Associate Phillip Wrabetz (IP & IT); Partner Ralf Peschek and Associate Dorothea Rauchegger (Employment); Partner Manfred Essletzbichler, Counsel Wolfgang Lauchner and Associate Dominik Koenig (Public Procurement) as well as Counsel Jochen Anweiler (Competition & Antitrust).

Read the full text

Download PDF

Contributors